Wei Lemaire

2.3k total citations
25 papers, 1.2k citations indexed

About

Wei Lemaire is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, Wei Lemaire has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Biochemistry. Recurrent topics in Wei Lemaire's work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (7 papers) and Amino Acid Enzymes and Metabolism (6 papers). Wei Lemaire is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (7 papers) and Amino Acid Enzymes and Metabolism (6 papers). Wei Lemaire collaborates with scholars based in United States and United Kingdom. Wei Lemaire's co-authors include Cyrille Sur, P. Jeffrey Conn, David L. Williams, Craig W. Lindsley, Julie A. O’Brien, Douglas J. Pettibone, Marlene A. Jacobson, Gene G. Kinney, Maryann Burno and Mark E. Duggan and has published in prestigious journals such as Journal of Neuroscience, Analytical Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Wei Lemaire

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Lemaire United States	16	881	784	189	148	122	25	1.2k
Hugh J. Herdon United Kingdom	20	790 0.9×	692 0.9×	154 0.8×	108 0.7×	45 0.4×	39	1.2k
H.C. Neijt Switzerland	18	1.1k 1.3×	801 1.0×	299 1.6×	47 0.3×	79 0.6×	20	1.6k
P. Malherbe Switzerland	11	481 0.5×	555 0.7×	143 0.8×	26 0.2×	48 0.4×	15	973
Pierre Mallorga United States	19	932 1.1×	855 1.1×	129 0.7×	164 1.1×	164 1.3×	43	1.6k
Shujia Zhu China	17	763 0.9×	690 0.9×	114 0.6×	67 0.5×	42 0.3×	38	1.2k
T. Honoré Denmark	23	1.9k 2.1×	1.2k 1.6×	314 1.7×	82 0.6×	199 1.6×	33	2.2k
Т. А. Гудашева Russia	22	946 1.1×	771 1.0×	64 0.3×	57 0.4×	172 1.4×	299	1.8k
D D Schoepp United States	15	1.5k 1.7×	922 1.2×	419 2.2×	37 0.3×	92 0.8×	18	1.8k
Takato Hiranita United States	27	1.0k 1.2×	936 1.2×	122 0.6×	373 2.5×	342 2.8×	87	1.9k
Toshiharu Shimazaki Japan	17	728 0.8×	390 0.5×	151 0.8×	47 0.3×	62 0.5×	31	1.2k

Countries citing papers authored by Wei Lemaire

Since Specialization

Citations

This map shows the geographic impact of Wei Lemaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lemaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lemaire more than expected).

Fields of papers citing papers by Wei Lemaire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lemaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lemaire. The network helps show where Wei Lemaire may publish in the future.

Co-authorship network of co-authors of Wei Lemaire

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Lemaire. A scholar is included among the top collaborators of Wei Lemaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Lemaire. Wei Lemaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jinn, Sarah, Lihang Yao, Monika Kandebo, et al.. (2021). A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiology of Disease. 159. 105507–105507. 14 indexed citations

Finley, Michael, Kelli Solly, Michelle K. Clements, et al.. (2016). Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5. SLAS DISCOVERY. 21(5). 480–489. 5 indexed citations

Roecker, Anthony J., Swati P. Mercer, Jeffrey M. Bergman, et al.. (2015). Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorganic & Medicinal Chemistry Letters. 25(21). 4992–4999. 14 indexed citations

Roecker, Anthony J., Swati P. Mercer, C. Meacham Harrell, et al.. (2014). Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis. Bioorganic & Medicinal Chemistry Letters. 24(9). 2079–2085. 9 indexed citations

Nanda, Kausik K., Darrell A. Henze, Kimberly Della Penna, et al.. (2013). Benzimidazole CB2 agonists: Design, synthesis and SAR. Bioorganic & Medicinal Chemistry Letters. 24(4). 1218–1221. 22 indexed citations

Trotter, B. Wesley, Kausik K. Nanda, Christopher S. Burgey, et al.. (2011). Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(8). 2354–2358. 50 indexed citations

Zhao, Zhijian, William Leister, Julie A. O’Brien, et al.. (2009). Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1488–1491. 16 indexed citations

Wolkenberg, S. E., Zhijian Zhao, David D. Wisnoski, et al.. (2009). Discovery of GlyT1 inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(5). 1492–1495. 15 indexed citations

Bergman, Jeffrey M., Anthony J. Roecker, Swati P. Mercer, et al.. (2008). Proline bis-amides as potent dual orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(4). 1425–1430. 54 indexed citations

10.

Zeng, Zhizhen, Julie A. O’Brien, Wei Lemaire, et al.. (2008). A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies. Nuclear Medicine and Biology. 35(3). 315–325. 23 indexed citations

11.

Zhao, Zhijian, Julie A. O’Brien, Wei Lemaire, et al.. (2006). Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides. Bioorganic & Medicinal Chemistry Letters. 16(23). 5968–5972. 12 indexed citations

12.

Lindsley, Craig W., Zhijian Zhao, William Leister, et al.. (2006). Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides. ChemMedChem. 1(8). 807–811. 32 indexed citations

13.

Wisnoski, David D., Julie A. O’Brien, Wei Lemaire, et al.. (2006). Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA. Bioorganic & Medicinal Chemistry Letters. 17(5). 1386–1391. 58 indexed citations

14.

Kinney, Gene G., Julie A. O’Brien, Wei Lemaire, et al.. (2005). A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models. Journal of Pharmacology and Experimental Therapeutics. 313(1). 199–206. 229 indexed citations

15.

O’Brien, Julie A., Wei Lemaire, Marion Wittmann, et al.. (2004). A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain. Journal of Pharmacology and Experimental Therapeutics. 309(2). 568–577. 132 indexed citations

16.

O’Brien, Julie A., Wei Lemaire, Tsing‐Bau Chen, et al.. (2003). A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5. Molecular Pharmacology. 64(3). 731–740. 170 indexed citations

17.

Williams, David L., Julie A. O’Brien, Wei Lemaire, et al.. (2003). Difference in mGluR5 Interaction between Positive Allosteric Modulators from Two Structural Classes. Annals of the New York Academy of Sciences. 1003(1). 481–484. 2 indexed citations

18.

Williams, Jacinta B., Pierre Mallorga, Wei Lemaire, et al.. (2003). Development of a scintillation proximity assay for analysis of Na+/Cl−-dependent neurotransmitter transporter activity. Analytical Biochemistry. 321(1). 31–37. 21 indexed citations

19.

Kinney, Gene G., Cyrille Sur, Maryann Burno, et al.. (2003). The Glycine Transporter Type 1 InhibitorN-[3-(4′-Fluorophenyl)-3-(4′-Phenylphenoxy)Propyl]Sarcosine Potentiates NMDA Receptor-Mediated ResponsesIn Vivoand Produces an Antipsychotic Profile in Rodent Behavior. Journal of Neuroscience. 23(20). 7586–7591. 147 indexed citations

20.

Lemaire, Wei, Julie A. O’Brien, Maryann Burno, et al.. (2002). A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors. European Journal of Pharmacology. 450(1). 19–28. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact